956 research outputs found

    Youth Reproductive Health in Nepal: Is Participation the Answer?

    Get PDF
    Discusses the processes and results of a multi-year research study by ICRW, EngenderHealth, and Nepali partners, which tested the effectiveness of the participatory approach in defining and addressing the reproductive health concerns of adolescents

    Novel Biomarkers for the Diagnosis of Urinary Tract Infection—A Systematic Review

    Get PDF
    Urinary tract infections (UTIs) are associated with significant morbidity. We rely on clinical presentation, urinalysis, and urine culture to diagnose UTI. To differentiate between lower UTI and pyelonephritis, we depend on the clinical presentation. In the extremes of age and in immunocompromised individuals, clinical presentation is often atypical posing a challenge to diagnosis. In the elderly, the high prevalence of asymptomatic bacteriuria is another confounder. We conducted a search of publications to find novel biomarkers to diagnose UTI and to ascertain its severity. We searched PUBMED, MEDLINE and SCOPUS databases for studies pertaining to novel biomarkers and UTI. Two reviewers independently evaluated the methodology of the studies using the STARD (Standards for Reporting of Diagnostic Accuracy) criteria. We have identified procalcitonin as a biomarker to differentiate lower UTI from pyelonephritis in the pediatric age group. Elevated serum procalcitonin levels can result in early and aggressive treatment at the time of presentation. Interleukin 6 has also shown some promise in differentiating between lower UTI and pyelonephritis but needs further validation. Lastly, given the paucity of data in certain subgroups like diabetics, kidney transplant recipients, and individuals with spinal cord injury, further studies should be conducted in these populations to improve diagnostic criteria that will inform clinical management decisions

    Analysis of Various Decentralized Load Balancing Techniques with Node Duplication

    Get PDF
    Experience in parallel computing is an increasingly necessary skill for today’s upcoming computer scientists as processors are hitting a serial execution performance barrier and turning to parallel execution for continued gains. The uniprocessor system has now reached its maximum speed limit and, there is very less scope to improve the speed of such type of system. To solve this problem multiprocessor system is used, which have more than one processor. Multiprocessor system improves the speed of the system but it again faces some problems like data dependency, control dependency, resource dependency and improper load balancing. So this paper presents a detailed analysis of various decentralized load balancing techniques with node duplication to reduce the proper execution time

    Role of Dietary Management and Physical Activity in Control of Hypertension in Rural Areas of Punjab-A Cross-sectional Study

    Get PDF
    Introduction: As reported by WHO, hypertension is the third ‘killer’ disease, accounting for one in every eight deaths worldwide. Many modifiable and non-modifiable risk factors are found to be associated with the disease. The present study aims to determine the role of dietary management and physical activity in the control of hypertension in a given population. Material and Methods: A cross-sectional study was conducted that. Study included all hypertensive patients (290) from the field practice area of a tertiary care institute. A self-constructed, pretested questionnaire was used to enquire about the socio- demographic factors and other risk factors associated with hypertension. The data was analyzed using SPSS 23 and valid conclusions were drawn by using the chi-square test. Results: Out of 290 patients, 204 (70.3%) were females and 86 (29.7%) were males. Univariate analysis identified decreased salt intake, decreased fatty food consumption, physical activity, stress management, and spiritual help as highly significant factors affecting hypertension. On multivariate analysis, physical activity, stress management and spiritual help were found to be significant. Conclusion: The study showed that physical activity, stress management and spiritual help were significantly associated with hypertension control among the elderly. Measures should be taken to create awareness about lifestyle modifications in the control of hypertension

    Sustainable Management Strategies and Biological Control in Apple Orchards

    Get PDF
    Sustainable horticultural practices address the global issues of food security, pest and disease management, soil health, water pollution, depletion of biodiversity, etc. with environment–friendly approaches. Increasingly, the adoption of such strategies is benefitting agricultural production including that in orchards. Even though several Integrated Pest Management (IPM), disease, and weed management strategies have been in use for the control of pests, diseases, and weeds in apple orchards, they are still not the most favored methods of control. There are various economic and acceptance concerns regarding their use, particularly in developing nations. A more sustainable system for apple orchards management, thus, should be adopted.   Here, we review various management methodologies, including the sustainable biocontrol methods, employed in the apple orchards. Reviewing these methods, we draw attention towards integrating sustainable IPM methodologies with biocontrol strategies like the use of pest-resistant cultivars, employing natural parasites and enemies of apple pests, use of agro-based pesticides, integration of technological advances that can provide real-time data to farmers and orchard scouting leading to the development of sustainable management of apple orchards. Such systems will not only reduce dependence on chemical control methods but will also minimize ecotoxicity. We also draw parallels from the biocontrol methods adopted in sustainable agri-production in other fruit orchards to suggest strategies that can be employed for sustainable apple production

    Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1. The ENGAGE Randomized Clinical Trial

    Get PDF
    Importance Gaucher disease type 1 is characterized by hepatosplenomegaly, anemia, thrombocytopenia, and skeletal disease. A safe, effective oral therapy is needed. Objective To determine whether eliglustat, a novel oral substrate reduction therapy, safely reverses clinical manifestations in untreated adults with Gaucher disease type 1. Design, Setting, and Participants Phase 3, randomized, double-blind, placebo-controlled trial conducted at 18 sites in 12 countries from November 2009 to July 2012 among eligible patients with splenomegaly plus thrombocytopenia and/or anemia. Of 72 patients screened, 40 were enrolled. Interventions Patients were stratified by spleen volume and randomized 1:1 to receive eliglustat (50 or 100 mg twice daily; n = 20) or placebo (n = 20) for 9 months. Main Outcomes and Measures The primary efficacy end point was percentage change in spleen volume in multiples of normal from baseline to 9 months; secondary efficacy end points were change in hemoglobin level and percentage changes in liver volume and platelet count. Results All patients had baseline splenomegaly and thrombocytopenia (mostly moderate or severe), most had mild or moderate hepatomegaly, and 20% had mild anemia. Least-square mean spleen volume decreased by 27.77% (95% CI, −32.57% to −22.97%) in the eliglustat group (from 13.89 to 10.17 multiples of normal) vs an increase of 2.26% (95% CI, −2.54% to 7.06%) in the placebo group (from 12.50 to 12.84 multiples of normal) for an absolute treatment difference of −30.03% (95% CI, −36.82% to −23.24%; P < .001). For the secondary end points, the least-square mean absolute differences between groups all favored eliglustat, with a 1.22-g/dL increase in hemoglobin level (95% CI, 0.57-1.88 g/dL; P < .001), 6.64% decrease in liver volume (95% CI, −11.37% to −1.91%; P = .007), and 41.06% increase in platelet count (95% CI, 23.95%-58.17%; P < .001). No serious adverse events occurred. One patient in the eliglustat group withdrew (non–treatment related); 39 of the 40 patients transitioned to an open-label extension study. Conclusions and Relevance Among previously untreated adults with Gaucher disease type 1, treatment with eliglustat compared with placebo for 9 months resulted in significant improvements in spleen volume, hemoglobin level, liver volume, and platelet count. The clinical significance of these findings is uncertain, and more definitive conclusions about clinical efficacy and utility will require comparison with the standard treatment of enzyme replacement therapy as well as longer-term follow-up
    • …
    corecore